Document is current

Article History

Received: 5 May 2021

Accepted: 4 August 2021

First Online: 16 August 2021

Declarations

:

: The recipient of the questionnaire did receive supplementary information on the uses of the research results, names of those who conducted the survey, the name of the institution and contact information of the person conducting the research. Due to anonymous data collection a written consent form was not obtainable or required; however, we included a statement of implied consent as following: ‘Your willingness to return the completed questionnaire indicates your consent to participate in this study’.The study is approved by the Danish Data Protection Agency, Copenhagen, Denmark and the Danish Health and Medicines Authority, Copenhagen, Denmark (Jr. nr.: 17034371).

: Not applicable.

: Stefan Gustavsen has received support for congress participation from Merck. Anna Olsson has received support for congress participation from Roche and Novartis. Annette Oturai has served on scientific advisory boards for Biogen Idec has received research support from Novartis and Biogen Idec; has received speaker honoraria from Biogen Idec and Novartis; and has received support for congress participation from, Merck, Biogen, Roche and Sanofi Genzyme. Per Soelberg Sørensen, has received personal compensation for serving on scientific advisory boards, steering committees, independent data monitoring committees or have received speaker honoraria for Biogen, Merck, Novartis, TEVA, Celgene/BMS. Finn Sellebjerg has served on scientific advisory boards for, served as consultant for, received support for congress participation or received speaker honoraria from Alexion, Biogen, Merck, Novartis, Roche and Sanofi Genzyme. His laboratory has received research support from Biogen, Merck, Novartis, Roche and Sanofi Genzyme.Sven Robert Andresen and Helle Bach Søndergaard declare no conflict of interests.